Skip to content
★ Sign in to follow
AP

Antony Pfaffle

Executive
Total declarations
47
Company
1
▲ Purchases (1 ops.)
€493
▼ Sales (31 ops.)
€670k

Latest filing published 08 Feb 2017 for CorMedix Inc., €6,330.

Filing timeline

BuySale
Antony Pfaffle

Insider track record

Disclosed buys
1
Disclosed sells
31
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 19 Dec 2011 · 5439 days ago · €493
    +93.5%
    Entry US$1.55 · Close at T+365 US$3.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Antony Pfaffle: trading record in brief

All filings by Antony Pfaffle on record concern CorMedix Inc. In total, 47 filings cover trades dated from 30 March 2010 to 7 February 2017.

On the open market, the record shows 1 purchase worth €493 and 31 sales worth €670k. The net balance comes to €669k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 14 option exercises. So far in 2017, the count stands at no purchases and 1 sale.

Most recently, on 8 February 2017, the filings show an option exercise worth €6,330 in CorMedix Inc. The most recent open-market purchase was published on 19 December 2011, 5,439 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Antony Pfaffle

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations47 total
  • ◇
    Chief Scientific OfficerExecutivesCorMedix Inc.
    6,800 USD11SEC
    10,000 shares@ US$0.681.2% of flowCommon StockSEC:0001354488-17-000231:0
  • ▼
    Chief Scientific OfficerExecutivesCorMedix Inc.
    20,000 USD11SEC
    10,000 shares@ US$2.003.7% of flowCommon StockSEC:0001354488-17-000231:1
  • ◇
    Chief Scientific OfficerExecutivesCorMedix Inc.
    13,600 USD11SEC
    20,000 shares@ US$0.682.4% of flowCommon Stock, $0.001 par value per shareSEC:0001354488-16-008420:0
  • ▼
    Chief Scientific OfficerExecutivesCorMedix Inc.
    44,600 USD12SEC
    20,000 shares@ US$2.238.0% of flowCommon Stock, $0.001 par value per shareSEC:0001354488-16-008420:1
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    6,800 USD11SEC
    10,000 shares@ US$0.681.2% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:0
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    10,857 USD26SEC
    5,000 shares@ US$2.17131.9% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:1
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    10,712 USD26SEC
    5,000 shares@ US$2.14241.9% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:2
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    13,367 USD11SEC
    19,657 shares@ US$0.682.3% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:3
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    20,481 USD26SEC
    9,657 shares@ US$2.12083.6% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:4
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    15,173 USD26SEC
    7,181 shares@ US$2.1132.7% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:5
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    4,306 USD26SEC
    2,000 shares@ US$2.15290.8% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:6
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    1,812 USD26SEC
    819 shares@ US$2.21220.3% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001125:7
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    3,332 USD11SEC
    4,900 shares@ US$0.680.6% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001085:0
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    10,818 USD26SEC
    4,900 shares@ US$2.20771.9% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001085:1
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    3,400 USD11SEC
    5,000 shares@ US$0.680.6% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001075:0
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    11,406 USD26SEC
    5,000 shares@ US$2.28122.0% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001075:1
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    301 USD11SEC
    443 shares@ US$0.680.1% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001075:2
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    975 USD26SEC
    443 shares@ US$2.200.2% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001075:3
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    6,800 USD11SEC
    10,000 shares@ US$0.681.2% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001069:0
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    23,789 USD26SEC
    10,000 shares@ US$2.37894.1% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001069:1
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    8,636 USD11SEC
    12,700 shares@ US$0.681.5% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-000925:0
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    13,552 USD23SEC
    5,000 shares@ US$2.71032.4% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-000925:1
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    13,540 USD23SEC
    5,000 shares@ US$2.7082.4% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-000925:2
  • ▼
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    7,564 USD23SEC
    2,700 shares@ US$2.80151.3% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-000925:3
  • ◇
    Interim Chief Medical OfficerExecutivesCorMedix Inc.
    6,800 USD11SEC
    10,000 shares@ US$0.681.2% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-000922:0

25 of 47 declarations